Most Popular Stories
- Walgreens plans 100 more retail clinics by mid-2009
- Disruptive doctor behavior causes mistakes, intimidates workers
- AHA survey: Negative profit margins for hospitals
- DOD, VA move to SOA architecture to build interoperable systems
- Cleveland Clinic lists potential conflicts of interest online
- HHS: 60 percent of DME companies banned by Medicare may keep billing
Poll
Featured Jobs
-
Tennessee Vascular/General Surgeon
StaffPointe, LLC - near Nashville , TN -
Michigan OBGYN
StaffPointe, LLC - south , MI -
California Internal Medicine
StaffPointe, LLC - near San Diego , CA -
Florida Dermatology
StaffPointe, LLC - northeast , FL -
Florida Orthopedic Surgeon CEx1143
StaffPointe, LLC - near Fort Meyers , FL
Events
- Avaya Patient Payment Recovery Webinar
Thursday, December 11, 2008 1-2pm
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
- Emerging markets series: Benchmarking key countries Brazil, Russia, India, China and Turkey
Popular Topics
FDA to upgrade safety-data collection
June 21, 2006 — 8:01pm ET
The Food and Drug Administration will use a new web-based system to collect safety data on prescription drugs and medical devices. Agency officials say the new system will speed collection of data and allow internal departments to share information more effectively. The system could be online within two years.
- check out this article from the Minneapolis-St. Paul Star Tribune
Related Stories
- Study: Medicaid paid $198 million for unapproved drugs
- Boston ends Canadian drug import program, citing lack of interest
- FTC: Pharmas cut 14 deals to delay generic sales in '07
- FDA says hospitals may still have recalled heparin
- SPOTLIGHT: Should FDA's info be in all DTC ads?
- SPOTLIGHT: FDA needs database update, more staff, leaders say
- Biotechs eager for FDA approval of biogeneric drugs
- Vytorin, Avandia raise doubt on FDA approvals
- Did pharma ask the FDA for off-label rule change?
- FDA to further investigate anemia drug risks
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





